Symbol="KRTX"
AssetType="Common Stock"
Name="Karuna Therapeutics Inc"
Description="Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative drugs for people living with psychiatric and neurological conditions. The company is headquartered in Boston, Massachusetts."
CIK="1771917"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="33 ARCH STREET, SUITE 3110, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="7850322000"
EBITDA="-338368992"
PERatio="None"
PEGRatio="None"
BookValue="39.79"
DividendPerShare="0"
DividendYield="0"
EPS="-9.72"
RevenuePerShareTTM="0.343"
ProfitMargin="0"
OperatingMarginTTM="-30.07"
ReturnOnAssetsTTM="-0.213"
ReturnOnEquityTTM="-0.325"
RevenueTTM="11291000"
GrossProfitTTM="10637000"
DilutedEPSTTM="-9.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.857"
AnalystTargetPrice="277.24"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="162.38"
PriceToBookRatio="5.94"
EVToRevenue="138.07"
EVToEBITDA="-25.22"
Beta="1.031"
num_52WeekHigh="278.25"
num_52WeekLow="122.59"
num_50DayMovingAverage="223.71"
num_200DayMovingAverage="207.25"
SharesOutstanding="37444000"
DividendDate="None"
ExDividendDate="None"
symbol="KRTX"
open="210.94"
high="211.85"
low="205.12"
price="206.83"
volume="284984.00"
latest_trading_day="2023-07-18"
previous_close="209.66"
change="-2.83"
change_percent="-1.3475%"
aroon_positive_momentum_days="52"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="427342"
Change_recent_avg="0.05"
Delta_recent_avg="7.4"
Variance_recent_avg="3.7"
Change_ratio_recent_avg="-0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="1088"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_negative_thumbnail_id_2="175"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0001.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="621"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_positive_thumbnail_id_2="985"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
